Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong
NCT03330132Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Oct 2017
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent, influenza virus vaccine, split virion, influenza vaccine in influenza, sponsored by The University of Hong Kong. Started Oct 2017; status: completed.
02
Drugs
Fluzone Trivalentinfluenza virus vaccine, split virioninfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03330132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330132.